Quarterly Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7722374

Concept As at
2018-06-30
As at
2018-03-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
5,218,000,000 JPY
4,895,000,000 JPY
Securities
620,000,000 JPY
1,217,000,000 JPY
Merchandise and finished goods
1,570,000,000 JPY
1,759,000,000 JPY
Work in process
1,819,000,000 JPY
1,790,000,000 JPY
Raw materials and supplies
5,446,000,000 JPY
5,474,000,000 JPY
Other
766,000,000 JPY
592,000,000 JPY
Current assets
22,307,000,000 JPY
22,831,000,000 JPY
Non-current assets
Property, plant and equipment
10,683,000,000 JPY
10,853,000,000 JPY
Property, plant and equipment
Land
3,882,000,000 JPY
3,882,000,000 JPY
Construction in progress
5,000,000 JPY
JPY
Other
Other, net
2,092,000,000 JPY
2,215,000,000 JPY
Intangible assets
103,000,000 JPY
112,000,000 JPY
Intangible assets
Investments and other assets
4,717,000,000 JPY
4,600,000,000 JPY
Investments and other assets
Investment securities
3,276,000,000 JPY
3,194,000,000 JPY
Other
1,464,000,000 JPY
1,429,000,000 JPY
Allowance for doubtful accounts
-22,000,000 JPY
-22,000,000 JPY
Non-current assets
15,504,000,000 JPY
15,567,000,000 JPY
Assets
37,812,000,000 JPY
38,398,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
491,000,000 JPY
585,000,000 JPY
Short-term borrowings
3,434,000,000 JPY
2,893,000,000 JPY
Income taxes payable
278,000,000 JPY
887,000,000 JPY
Other
1,975,000,000 JPY
2,097,000,000 JPY
Current liabilities
7,188,000,000 JPY
7,105,000,000 JPY
Non-current liabilities
Long-term borrowings
1,950,000,000 JPY
2,500,000,000 JPY
Other
257,000,000 JPY
307,000,000 JPY
Non-current liabilities
3,172,000,000 JPY
3,764,000,000 JPY
Liabilities
10,360,000,000 JPY
10,870,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
10,936,000,000 JPY
10,947,000,000 JPY
Retained earnings
10,320,000,000 JPY
10,469,000,000 JPY
Treasury shares
-4,013,000,000 JPY
-4,042,000,000 JPY
Shareholders' equity
26,305,000,000 JPY
26,435,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
530,000,000 JPY
462,000,000 JPY
Valuation and translation adjustments
623,000,000 JPY
563,000,000 JPY
Share acquisition rights
337,000,000 JPY
344,000,000 JPY
Net assets
27,451,000,000 JPY
27,528,000,000 JPY
Liabilities and net assets
37,812,000,000 JPY
38,398,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.